April 25, 2011

Drug maker AP Pharma has appointed two new executives and may receive financing of up to $4.5 million, the company said Monday.

April 25, 2011

Anglo-Swedish drug maker AstraZeneca has made the drug vandetanib available to certain thyroid cancer patients.

April 25, 2011

As a specialty pharmacy provider, BioScrip probably isn’t the first name that comes to mind when one hears “retail pharmacy,” but its network of 31 community pharmacies around the country gives it a comfy spot at the table. The kinds of products and services it’s able to offer — ranging from home infusion and treatments for complex, chronic disease states to over-the-counter medications and sometimes even consumables — as a result of its combination of community pharmacy and specialty pharmacy make BioScrip stand out.


April 25, 2011


In the May issue of Consumer Reports, a report found that such independents as McKesson’s Health Mart franchise group are delivering the goods.


McKesson helped capitalize on what has always been an exemplary Health Mart patient experience at the top of last year with a multi-
million-dollar ad campaign that included an ad during the New Orleans Saints/Indianapolis Colts Super Bowl. That 2010 campaign featured real Health Mart pharmacists with stories on how they have impacted their local communities by taking the time to care and provide special services.


April 25, 2011

Chain pharmacies and independent pharmacies each have their advantages and disadvantages. Chains generally follow a top-down business model that requires all stores to be roughly identical in terms of their look and services, but they can offer those services to customers around the country. Independents’ services usually are limited to one or a handful of locations in a single geographic area, but they have more freedom in terms of their mix of products and services.


April 25, 2011

Mylan has launched a generic treatment for breast cancer, the drug maker said Monday.

April 25, 2011

On top of its 101 in-store pharmacies, Schnucks last year opened four specialty pharmacies, offering specialized services to patients.


The pharmacies offer services for patients living with such chronic conditions as HIV, cancer, multiple sclerosis and autoimmune diseases, as well as for people recovering from organ transplants, said company spokesman Paul Simon. “It’s for patients who require special attention and hard-to-source medication,” he added.


April 25, 2011

There’s nothing like a recession for focusing merchants on what matters most. For USA Drug, that meant concentrating on core markets, cutting costs and recharging its image for down-home value, neighborly service and a broadly merchandised front end focused on local consumer preferences.


April 22, 2011

Valeant Pharmaceuticals International is taking its case directly to Cephalon’s shareholders in its effort to acquire the Frazer, Pa.-based drug maker.

April 21, 2011

Specialty pharmacy provider Amber Pharmacy and pharmacy retailer Kubat Pharmacy have joined the first network to electronically exchange clinical patient information and medication therapy with healthcare providers in and around Nebraska, the Nebraska Health Information Initiative said Wednesday.

April 20, 2011

The Obama administration is looking to curb the growing national epidemic of prescription painkiller abuse, according to a plan unveiled Tuesday.

April 20, 2011

The Food and Drug Administration has approved a drug made by Genentech for the treatment of two rare inflammatory disorders, the agency said.

April 20, 2011

Sagent Pharmaceuticals has increased the number of shares it’s issuing in its initial public offering on the Nasdaq, the drug maker said Wednesday.

April 19, 2011

Drug maker Forest Labs has acquired worldwide rights to a drug developed by Procter & Gamble Pharmaceuticals for treating arrhythmia.

April 19, 2011

U.S. spending on drugs grew 2.3% to $307.4 billion in 2010, according to a new report by the IMS Institute for Healthcare Informatics, part of industry research firm IMS Health.

April 19, 2011

The Food and Drug Administration has given approval to Sigma-Tau Pharmaceuticals to manufacture the main ingredient of a treatment for leukemia, the drug maker said.

April 18, 2011

Healthcare is one of the fastest-growing segments of the American economy right now, and specialty pharmacy is no exception, especially as more baby boomers retire and as drug companies develop more sophisticated therapies.
But by growing, specialty pharmacy can add value to local economies, too. Specialty Pharmacy caught up with Diplomat president and CEO Phil Hagerman to talk about the company's growth strategies.

April 18, 2011

The Food and Drug Administration has approved a drug made by Genentech for treating a rare and severe form of arthritis that affects children, Genentech said.

April 18, 2011

At the upcoming 2011 Armada Specialty Pharmacy Summit in Las Vegas, Amber Pharmacy president Mike Agostino — recently appointed to the Board of Advisors of Specialty Pharmacy — will give a presentation focused on the specialty pharmacy marketplace and the importance of customers. Specialty Pharmacy had the chance to talk with Agostino about the contents of his presentation and his new role.

April 14, 2011

CVS Caremark has unveiled a new medical benefit drug management service for its pharmacy benefit manager and specialty pharmacy clients.

April 14, 2011

Despite a difficult economy and rising health costs, the benefits of an integrated pharmacy service were evident as CVS Caremark helped its pharmacy benefit manager clients — employers, health plans and third-party administrators — manage pharmacy costs, according to the company's annual "Insights Report."

April 13, 2011

Cephalon has lodged a bidder’s statement to acquire Australian drug maker ChemGenex Pharmaceuticals for $167 million, Cephalon said Wednesday.

April 13, 2011

The Food and Drug Administration has accepted a regulatory approval application for a topical treatment for low testosterone made by Teva Pharmaceuticals and BioSante Pharmaceuticals, BioSante said Wednesday.

April 13, 2011

A Food and Drug Administration expert panel has given a favorable vote to a drug made by Pfizer for tumors, Pfizer said Tuesday.